Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

53.18
Delayed Data
As of 3:59pm ET
 -0.075 / -0.14%
Today’s Change
31.38
Today|||52-Week Range
80.11
+42.03%
Year-to-Date
Alnylam (ALNY) Up 14.5% Since Earnings Report: Can It Continue?
7:17am / Zacks.com - Paid Partner Content
Alnylam's LDL-Lowering Drug Positive in Phase II Study
Mar 20 / Zacks.com - Paid Partner Content
Regenxbio Leads Biotech Movers Ahead of Market's Open
Mar 22 / TheStreet.com - Paid Partner Content
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic PLC, Se...
Mar 20 / GuruFocus News - Paid Partner Content